Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis
- PMID: 1347196
- PMCID: PMC1684269
Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis
Abstract
Loss of heterozygosity for sequences located on chromosome 17p in several tumor types is often associated with mutations in the tumor suppressor gene p53. We previously showed consistent deletion of chromosome 17p12-13.1 in medulloblastoma, a common childhood brain tumor. Using denaturing gradient gel electrophoresis and direct sequencing, we have detected p53 mutations in only two of 20 medulloblastoma specimens. Moreover, additional RFLP studies of these 20 specimens showed loss of heterozygosity at a more distal and distinct site, 17p13.3. Deletion of 17p almost invariably signified a negative prognosis. Our results suggest that p53 mutations may contribute to the pathogenesis of medulloblastoma in relatively few cases. The consistent deletion of other discrete loci on 17p suggests that additional or alternative tumor suppressor genes may contribute to the tumor's phenotype.
Similar articles
-
Tumor suppressor genes and medulloblastoma.J Neurooncol. 1996 Jul;29(1):103-12. doi: 10.1007/BF00165523. J Neurooncol. 1996. PMID: 8817421 Review.
-
Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.Cancer Genet Cytogenet. 1997 Aug;97(1):25-31. doi: 10.1016/s0165-4608(96)00319-6. Cancer Genet Cytogenet. 1997. PMID: 9242214
-
Deletion mapping of the medulloblastoma locus on chromosome 17p.Genomics. 1990 Oct;8(2):279-85. doi: 10.1016/0888-7543(90)90283-z. Genomics. 1990. PMID: 1979050
-
p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.Diagn Mol Pathol. 1993 Mar;2(1):23-8. Diagn Mol Pathol. 1993. PMID: 8287222
-
Chromosome 17p deletion in human medulloblastoma: a missing checkpoint in the Hedgehog pathway.Cell Cycle. 2004 Oct;3(10):1263-6. doi: 10.4161/cc.3.10.1200. Epub 2004 Oct 3. Cell Cycle. 2004. PMID: 15467454 Review.
Cited by
-
The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.Neuro Oncol. 2009 Aug;11(4):381-93. doi: 10.1215/15228517-2008-110. Epub 2008 Dec 16. Neuro Oncol. 2009. PMID: 19088174 Free PMC article.
-
Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours.Hum Genet. 1995 Dec;96(6):684-90. doi: 10.1007/BF00210300. Hum Genet. 1995. PMID: 8522328
-
Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.Jpn J Cancer Res. 1998 Apr;89(4):347-51. doi: 10.1111/j.1349-7006.1998.tb00569.x. Jpn J Cancer Res. 1998. PMID: 9617337 Free PMC article.
-
Genetics of primary brain tumors: a review.J Neurooncol. 1994;18(1):69-81. doi: 10.1007/BF01324606. J Neurooncol. 1994. PMID: 8057137 Review.
-
Molecular biology of pediatric gliomas.J Neurooncol. 1996 May-Jun;28(2-3):121-8. doi: 10.1007/BF00250194. J Neurooncol. 1996. PMID: 8832457 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous